$Aerpio Pharmaceuticals Inc(ARPO)$no bad news from the meeting. In fact, the potential NDA approval from the FDA in the coming months might set ARPO up for a HUGE run. Havingpassed trial 1 & 2 is no easy task. But ARPO has already done so with its groundbreaking FYARRO technology which can potentially help with cancer and many other diseases, so the potential is limitless!
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
3
举报
登录后可参与评论
暂无评论